Apollon

04/18/2024

We need a mechanical design engineer in Seoul and research scientists in optics in Boston. Up to now, we've raised about $3 million in capital. Using Raman technology, we are making a non-invasive CGM and are currently in clinical trials with MIT to show how well our small device works.

서울에서 Pre-A 투자에 대한 기사가 났습니다. 우리의 목적은 하나, 기구설계 엔지니어(서울)와 광학 연구원(보스턴)을 만나는 것입니다. 우리 같이 바늘 없는 초소형 혈당측정기 한번 만들어보지 않을래요? 🤗

아폴론은 23억원 규모의 프리(Pre)-A 투자를 유치했다고 밝혔다. 이번 투자는 지난해 11월 시드투자에 이어 내년 초 계획 중인 시리즈A를 이어주는 브릿지 라운드로 KB인베스트먼트, 스틱벤처스, 비하이인베스트먼트

11/14/2023

The World Diabetes Day is on November 14, which is also the day Apollon was established in the States. We are going to simplify and lower the cost of blood sugar control!

10/16/2023

We completed our seed investment in the first half of the year, and as a result, we were selected for the TIPS (Tech Incubator Program for startup Korea), in which the Korean government matches up to $500,000 in investment capital.

#바늘 없는 #연속혈당측정기( )를 개발하는 #아폴론이 ' #팁스( )'에 최종 선정됐다.

09/08/2023

Apollon and MIT Commence Collaboration to Develop Continuous Non-Invasive Glucose Monitoring Technology

Developmental wearable technology is said to perform better than existing non-invasive products.